Clinical trials
Phase 4 Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
184 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 7 |
| 2003 | 5 |
| 2004 | 7 |
| 2005 | 11 |
| 2006 | 3 |
| 2007 | 8 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 8 |
| 2011 | 7 |
| 2012 | 5 |
| 2013 | 5 |
| 2014 | 12 |
| 2015 | 12 |
| 2016 | 12 |
| 2017 | 19 |
| 2018 | 16 |
| 2019 | 10 |
| 2020 | 7 |
| 2021 | 3 |
| 2022 | 7 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 108 |
| Unknown status | 25 |
| Terminated | 22 |
| Withdrawn | 20 |
| Recruiting | 3 |
| Not yet recruiting | 3 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kirby Institute | 9 |
| Massachusetts General Hospital | 9 |
| Merck Sharp & Dohme LLC | 5 |
| National Taiwan University Hospital | 5 |
| University of Maryland, Baltimore | 5 |
| Brooke Army Medical Center | 4 |
| Johns Hopkins University | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
| University of California, San Francisco | 4 |
| Instituto de Investigación Marqués de Valdecilla | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 184 |
| Hepatitis C, Chronic | 34 |
| Acquired Immunodeficiency Syndrome | 13 |
| HIV Infections | 13 |
| Fibrosis | 8 |
| Liver Diseases | 7 |
| Renal Insufficiency | 7 |
| Kidney Failure, Chronic | 6 |
| Hepatitis | 5 |
| Insulin Resistance | 5 |
Trials
Showing 1 to 25 of 184. Each trial links to its page on Pharma Observatory.
84 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.